NCT03958643View on ClinicalTrials.gov

Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

May 24, 2019

Primary Completion Date

May 1, 2021

Study Completion Date

February 8, 2022

Conditions
Sickle Cell Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT03958643 - Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy | Biotech Hunter | Biotech Hunter